Peer-facilitated treatment access for hepatitis C: the Live Hep C Free project

被引:9
|
作者
Silano, Julia A. [1 ]
Treloar, Carla [2 ]
Leadbeatter, Kyle [3 ]
Davidson, Sandy [3 ]
Doidge, Justine [3 ]
机构
[1] McMaster Univ, Hamilton, ON, Canada
[2] Univ New South Wales, Sydney, NSW, Australia
[3] Hepatitis NSW, Sydney, NSW, Australia
关键词
Hepatitis C; Peer workers; Socially marginalised groups; Community-based HCV care; INJECT DRUGS; VIRUS; PEOPLE; CARE; ELIMINATION; AUSTRALIA; SERVICES; BARRIERS;
D O I
10.1186/s12954-022-00619-3
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background This commentary explores the lessons learned during implementation of a peer-facilitated hepatitis C virus (HCV) testing and treatment access project called the Live Hep C Free (LHCF) project in contributing to micro-elimination efforts. Case presentation The LHCF project aims to facilitate access to on-the-spot HCV testing, treatment, and care in priority settings through partnership between a peer worker (PW) and a clinical nurse. Since the start of the project in January 2018, 4515 people were engaged about HCV and encouraged to access on-site HCV health care, and over 1000 people were screened for HCV and liver health, while almost 250 people accessed HCV treatment through the project. This commentary is intended to prompt discussion about incorporating peer-centred HCV health programs into priority sites. HCV care-delivery models such as the LHCF project can continue to contribute to micro-elimination of HCV in key settings to increase treatment uptake amongst high prevalence and/or marginalised populations and support progress toward national elimination targets. Conclusions The LHCF project has been able to highlight the benefits of incorporating trustworthy, efficient, and convenient peer-centred health services to engage and support vulnerable populations through HCV testing and treatment, particularly individuals who have historically been disconnected from the health care system. Additional attention is needed to ensure ongoing funding support to sustain the project and deliver at scale and in expanding evaluation data to examine the operation and outcomes of the project in more detail.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Access to Treatment of Hepatitis C in Prison Inmates
    Paul Strock
    Joël Mossong
    Karine Hawotte
    Vic Arendt
    Digestive Diseases and Sciences, 2009, 54
  • [22] Access to Treatment of Hepatitis C in Prison Inmates
    Strock, Paul
    Mossong, Joel
    Hawotte, Karine
    Arendt, Vic
    DIGESTIVE DISEASES AND SCIENCES, 2009, 54 (06) : 1325 - 1330
  • [23] Bridging the gap: Addressing disparities in hepatitis C screening, access to care, and treatment outcomes
    Alenzi, Maram
    Almeqdadi, Mohammad
    WORLD JOURNAL OF HEPATOLOGY, 2024, 16 (08)
  • [24] Treatment access is only the first step to hepatitis C elimination: experience of universal anti-viral treatment access in Australia
    Doyle, Joseph S.
    Scott, Nick
    Sacks-Davis, Rachel
    Pedrana, Alisa E.
    Thompson, Alexander J.
    Hellard, Margaret E.
    Dietze, Paul
    McBryde, Emma
    Sievert, William
    Stoove, Mark
    Higgs, Peter
    Petrie, Denis
    Vickerman, Peter
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 49 (09) : 1223 - 1229
  • [25] Heterogeneity in hepatitis C treatment prescribing and uptake in Australia: a geospatial analysis of a year of unrestricted treatment access
    Scott, Nick
    Hainsworth, Samuel W.
    Sacks-Davis, Rachel
    Pedrana, Alisa
    Doyle, Joseph
    Wade, Amanda
    Hellard-, Margaret
    JOURNAL OF VIRUS ERADICATION, 2018, 4 (02) : 108 - 114
  • [26] Managing expense and expectation in a treatment revolution: Problematizing prioritisation through an exploration of hepatitis C treatment 'benefit'
    Harris, Magdalena
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2017, 47 : 161 - 168
  • [27] Hepatitis C Virus Treatment: Is It Possible To Cure All Hepatitis C Virus Patients?
    Muir, Andrew J.
    Naggie, Susanna
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (12) : 2166 - 2172
  • [28] Client resistance to hepatitis C treatment initiation in opioid agonist treatment clinics in Sydney, Australia: A qualitative study
    Coupland, Heidi
    Day, Carolyn
    Haber, Paul
    Pritchard-Jones, Janice
    McKee, Kristen
    George, Jacob
    McCaughan, Geoff
    DRUG AND ALCOHOL REVIEW, 2022, 41 (03) : 706 - 714
  • [29] Improving patient access to hepatitis C virus treatment
    McLaughlin, Milena M.
    Marx, Kevin T.
    Terriff, Colleen
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2018, 58 (01) : 109 - +
  • [30] Negotiating access to medical treatment and the making of patient citizenship: the case of hepatitis C treatment
    Rhodes, Tim
    Harris, Magdalena
    Martin, Anthea
    SOCIOLOGY OF HEALTH & ILLNESS, 2013, 35 (07) : 1023 - 1044